Details van artikel 130 van 418 gevonden artikelen
PD-023 Safety across subgroups in NAPOLI-1: a phase 3 study of nal-IRI (MM-398) ± 5-fluorouracil and leucovorin (5-FU/LV) versus 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy
Titel:
PD-023 Safety across subgroups in NAPOLI-1: a phase 3 study of nal-IRI (MM-398) ± 5-fluorouracil and leucovorin (5-FU/LV) versus 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy
Auteur:
Chen, L.-T. Siveke, J. Wang-Gillam, A. Hubner, R. Pant, S. Dragovich, T. Chung, V. Chang, D. Ross, P. Cooray, P. Tebbutt, N. Franke, F. Belanger, B. Dhindsa, N. de Jong, F. Mamlouk, K. Von Hoff, D.
Verschenen in:
Annals of oncology
Paginering:
Jaargang 27 () nr. S2 pagina's ii110
Jaar:
2016
Inhoud:
Uitgever:
European Society for Medical Oncology
Bronbestand:
Elektronische Wetenschappelijke Tijdschriften
Details van artikel 130 van 418 gevonden artikelen